159 related articles for article (PubMed ID: 3366182)
1. Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat.
Decktor DL; Pendleton RG; Elnitsky AT; Jenkins AM; McDowell AP
Eur J Pharmacol; 1988 Mar; 147(2):313-6. PubMed ID: 3366182
[TBL] [Abstract][Full Text] [Related]
2. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
Green T; Dimaline R; Peikin S; Dockray GJ
Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
[TBL] [Abstract][Full Text] [Related]
3. A model of gastric emptying in cats shows solid emptying is promoted by MK-329: a CCK antagonist.
Gould RJ; Fioravanti C; Cook PG; Solomon HF
J Nucl Med; 1990 Sep; 31(9):1494-9. PubMed ID: 2203881
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):406-13. PubMed ID: 12690433
[TBL] [Abstract][Full Text] [Related]
5. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by estradiol in ovariectomized rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
Scand J Gastroenterol; 2002 Oct; 37(10):1133-9. PubMed ID: 12408516
[TBL] [Abstract][Full Text] [Related]
6. The effect of the cholecystokinin antagonist devazepide (L364718) on the ileal brake mechanism in the rat.
Brown NJ; Rumsey RD; Read NW
J Pharm Pharmacol; 1993 Dec; 45(12):1033-6. PubMed ID: 7908970
[TBL] [Abstract][Full Text] [Related]
7. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
Varga G; Scarpignato C
Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
[TBL] [Abstract][Full Text] [Related]
8. Voluntary intake and gastric emptying in pigs: effects of fat and a CCK inhibitor.
Rayner DV; Miller S
Physiol Behav; 1993 Nov; 54(5):917-22. PubMed ID: 8248383
[TBL] [Abstract][Full Text] [Related]
9. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.
Nishida A; Yuki H; Tsutsumi R; Miyata K; Kamato T; Ito H; Yamano M; Honda K
Jpn J Pharmacol; 1992 Feb; 58(2):137-45. PubMed ID: 1354760
[TBL] [Abstract][Full Text] [Related]
10. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
[TBL] [Abstract][Full Text] [Related]
11. Effect of metoclopramide and bethanechol on gastric emptying in infants.
Hyman PE; Abrams C; Dubois A
Pediatr Res; 1985 Oct; 19(10):1029-32. PubMed ID: 3903644
[TBL] [Abstract][Full Text] [Related]
12. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
Wu CL; Doong ML; Wang PS
Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
[TBL] [Abstract][Full Text] [Related]
13. Endogenous cholecystokinin in the control of gastric emptying of liquid nutrient loads in rhesus monkeys.
Moran TH; Ameglio PJ; Schwartz GJ; Peyton HJ; McHugh PR
Am J Physiol; 1993 Aug; 265(2 Pt 2):R371-5. PubMed ID: 8368391
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang JL; Wang PS
Pflugers Arch; 2002 Nov; 445(2):187-93. PubMed ID: 12457239
[TBL] [Abstract][Full Text] [Related]
15. Effect of cholecystokinin on gastric motility in humans.
Beglinger C
Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
[TBL] [Abstract][Full Text] [Related]
16. Effect of CCK and its antagonists on gastric emptying.
Scarpignato C; Varga G; Corradi C
J Physiol Paris; 1993; 87(5):291-300. PubMed ID: 8298606
[TBL] [Abstract][Full Text] [Related]
17. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
[TBL] [Abstract][Full Text] [Related]
18. Increasing antidumping effect of intestinal pacing with motor-active agents.
Morrison PD; Kelly KA
Dig Dis Sci; 1986 Apr; 31(4):422-7. PubMed ID: 2869925
[TBL] [Abstract][Full Text] [Related]
19. Effects of evodiamine on gastrointestinal motility in male rats.
Wu CL; Hung CR; Chang FY; Lin LC; Pau KY; Wang PS
Eur J Pharmacol; 2002 Dec; 457(2-3):169-76. PubMed ID: 12464363
[TBL] [Abstract][Full Text] [Related]
20. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G
Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
